IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.
Clin Cancer Res. 2012; 18(9):2490-501
Zvi Ram and Rachel Grossman
25 Jun 2012
|
New Finding
This paper suggests a new classification based on molecular profile of lower grade diffuse astrocytic glioma predictive of overall survival.
World Health Organization (WHO) II and III diffuse astrocytic gliomas are defined by histopathology; however, lately it became clear that they represent a spectrum of closely related pathologies....
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.